Download The Northern Cancer Alliance – Challenges and Opportunities – Mr

The Northern Cancer Alliance:
Challenges and Opportunities
Mr Andy Welch
Chair
Northern Cancer Alliance
North East and North Cumbria
www.necn.nhs.uk
Development of the Northern
Cancer Alliance
The Alliance foot print agreement was based on a
number of factors including:
•
Population base
•
Patient flows
•
Service pathway interdependencies
•
Existing organisational relationships
•
Deliverability
•
Patient Groups
•
Resource implications, including economies of scale
Alliance Vision
Our goal is to increase cancer survival rates
across this region, ensuring that we reduce
inequalities, deliver the best possible outcomes
for every patient affected by cancer and the best
possible patient experience.
Northern Cancer Alliance
Challenges
• Health inequalities
• Increase in demand
– diagnostic services
• Ageing population
• Workforce
• Spread of deprivation
• Performance
• Variation
• Rurality of geography
• Collaborative
decision making
Proportion of Cases Stage 1 or 2 - 2014 Registrations
60%
CCG
Network
England
50%
40%
30%
20%
10%
0%
48.3%
49.5%
50.3%
51.1%
51.1%
51.3%
52.7%
53.6%
53.8%
54.4%
54.5%
55.0%
N Tyne
N Durham
DDES
HAST
New/Gates
S Tyne
Stees
Nland
Sland
Cumbria
HRW
Darlington
59.0
59.5
57.8
57.4
56.9
56.7
56.2
56.5
56.0
53.9
53.4
NHS Cumbria CCG
NHS Sunderland CCG
NHS Northumberland CCG
NHS North Durham CCG
NHS Newcastle Gateshead CCG
NHS Hartlepool and Stocktonon-Tees CCG
NHS North Tyneside CCG
NHS Darlington CCG
NHS South Tyneside CCG
NHS Durham Dales, Easington
and Sedgefield CCG
0
NHS South Tees CCG
1 year Survival Index (%)- All Cancers by CCG - 2013 - with England Comparison
All Ages and >75
80
All Ages
70.1
69.8
69.4
Age >75
All Ages - England
Age >75 England
70
60
68.9
68.8
68.4
68.1
67.7
67.1
67.0
66.1
50
40
30
20
10
Opportunities
– Allows networked services across the region
– Allows the collaboration and integration with our 3
STPs
– Transformation funds to address specific targeted
interventions
• redesign of cancer pathways
• best patient flow for diagnosis and treatment of all our
patients.
Structure slide
North Region Cancer Taskforce
Provider
Boards/Governing
Bodies
North Region
ALLIANCE
BOARD
Clinical
Leadership
Group
PREVENTION
LIVING WITH AND
BEYOND CANCER
Site Specific Expert Reference Groups
•
•
•
•
•
•
•
Brain and Central Nervous System
Breast
Colorectal
Gynae-Oncology
Haematology
Head and Neck
Hepato Pancreatic Biliary (HPB)
Cancer Managers
Version 0.8 March 2017
•
•
•
•
•
•
•
North CCG
Forum
Commissioning
Forum
PATIENT
EXPERIENCE
EARLY
DIAGNOSIS
Commissioning
Boards/Governing
Bodies
STP Partnership
Boards
Lung
Oesophagogastric (OG)
Psychology
Sarcoma
Skin
Thyroid
Urology
Cancer in the
Community
and
•
•
•
•
•
HIGH QUALITY
MODERN SERVICES
COMMISSIONING, PROVISION
AND ACCOUNTABILITY
INFORMATION
AND DATA
Cross Cutting Expert Reference Groups
Acute Oncology / Metastatic Spinal
Cord Compression / Cancer of
Unknown Primary
Chemotherapy
Genetics
Histopathology
CYPCG
•
•
•
•
Cancer Locality
Groups
Public Health England
Psychological Health
Radiology
Radiotherapy
Supportive, Palliative and End of
Life Care
HCPH Network
Attended by
Alliance Manager
Local Authority, Public Health
Priorities
Prevention
• decrease smoking prevalence by increasing uptake of smoking cessation
service
• embed secondary prevention model in cancer pathways
Awareness
• increase community awareness and cancer education; increase screening
uptake
• review communications to improve earlier presentation with symptoms
Early diagnosis
• improve GP use of 2ww urgent referral route; GP direct access to diagnostic
tests
Priorities
Audit
• increase use of SEA audit in primary care; audit emergency
presentations
Services
• review provision of radiotherapy across Alliance
• include patients in redesign of pathways and services
Patients
• improve performance in Cancer Patient Experience Survey.
Priorities
Diagnostics
• scope diagnostic capacity and projected demand in radiology, endoscopy,
pathology
• create academy of pathologists, networked radiology diagnostic services
Workforce
• Liaison with HEE- radiologists and pathologists; train wider cancer workforce
in new skills and roles
Pathways
• redesign pathways to accommodate Alliance requirements: commencing with
lung, upper/lower GI, urology
• introduce new ‘vague symptoms’ pathway; very urgent referral route
Measurements of success –
by 2020
•
•
•
•
•
•
Increase the proportion of patients with a recorded cancer
stage
Increase the proportion of cancers diagnosed at stage 1 and 2
Ensure 95% of patients referred for testing are definitively
diagnosed, or cancer is excluded, within four weeks
Increased 1 year survival
Direct GP access to diagnostic tests with timely reporting
Conform to cancer waiting time standards – may be modified
Operational Success
Entirely dependent on clinical ‘buy in’